Sikander Ailawadhi MD

Hematologic Oncology

Professor of Medicine, Lead for International Cancer Center, Divisions of Hematology/Oncology and Cancer Biology, Department of Medicine

Join to view full profile

4500 San Pablo Road SJacksonville, FL 32224

Dr. Ailawadhi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ailawadhi's full profile Already have an account?

Education & Training

University at BuffaloFellowship, Hematology and Medical Oncology, 2006 - 2008
University at BuffaloResidency, Internal Medicine, 2003 - 2006
Delhi University College of Medical SciencesClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2013 - 2028
TN State Medical License 2020 - 2023
CA State Medical License 2007 - 2013
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Powerchart (Image Results), Cerner Corporation, 2014-2015, 2017
CMS Meaningful Use Stage 1 Certification FirstNet (Image Results), Cerner Corporation, 2014-2015, 2017
CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014-2015, 2017

Clinical Trials

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
COMPLETED
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
COMPLETED
Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant Start of enrollment: 2017 Mar 10
TERMINATED
PHASE1

Publications & Presentations

PubMed

Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia.
Sikander Ailawadhi, Elcin Omercikoglu, Aneel Paulus, Ricardo D Parrondo, Asher A Chanan-Khan
Drug Safety. 2026-10-01
Prospective patient preference study for chronic lymphocytic leukemia (CLL) treatment attributes impacting patient shared decision-making.
Sikander Ailawadhi, Swetha Challagulla, Yan Meng, Todor I Totev, Dominic Pilon
Expert Review of Anticancer Therapy. 2026-09-23
Quantitative bias analyses to address measurement error in time-to-event endpoints.
Benjamin Ackerman, Ryan W Gan, Youyi Zhang, Jennifer Hayden, Jocelyn R Wang
American Journal of Epidemiology. 2026-09-03

Journal Articles

Targeting CD38 with Daratumumab Is Lethal to Waldenström Macroglobulinaemia Cells
Richard Furman, Stephen M Ansell, Sikander Ailawadhi, Thomas E Witzig, Vivek Roy, Taimur Sher, Liuyan Jiang, British Journal of Haematology
Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...
John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature

Abstracts/Posters

Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect¬ MM R...
Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)
Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance
Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Racial Disparities in Multiple Myeloma Care
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Evolving Real-World Treatment Patterns in Patients with Newly-Diagnosed Multiple Myeloma (NDMM) in the United States (U.S.)
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Significant Treatment Advances in Multiple Myeloma Presented at ASCO 2025June 17th, 2025
Ask Me Anything: LymphomaMarch 25th, 2025
Press Release: New Sarclisa Subcutaneous Formulation Met Co-Primary Endpoints in the IRAKLIA Phase 3 Study in Multiple MyelomaJanuary 9th, 2025

Professional Memberships

American Society of Hematology - ASH
Member
American Society of Clinical Oncology - ASCO
Member

Other Languages

Hindi

External Links

Mayo Clinic Profilehttps://www.mayoclinic.org/biographies/ailawadhi-sikander-m-d/bio-20087330
Patient Referralhttps://www.mayoclinic.org/medical-professionals/provider-relations/refer-patient